T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 9.31 CNY -0.96%
Market Cap: 4.8B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Teyi Pharmaceutical Group Co Ltd

Revenue
777.5m CNY
Cost of Revenue
-440.7m CNY
Gross Profit
336.8m CNY
Operating Expenses
-264.6m CNY
Operating Income
72.2m CNY
Other Expenses
-1.5m CNY
Net Income
70.7m CNY

Income Statement
Teyi Pharmaceutical Group Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
347
N/A
345
-1%
355
+3%
356
+0%
419
+17%
517
+23%
584
+13%
631
+8%
648
+3%
656
+1%
651
-1%
680
+5%
689
+1%
687
0%
739
+8%
777
+5%
828
+7%
885
+7%
926
+5%
949
+2%
939
-1%
921
-2%
852
-8%
743
-13%
668
-10%
633
-5%
652
+3%
691
+6%
725
+5%
758
+5%
758
0%
785
+4%
816
+4%
887
+9%
996
+12%
1 040
+4%
1 049
+1%
1 067
+2%
928
-13%
843
-9%
778
-8%
Gross Profit
Cost of Revenue
(200)
(192)
(205)
(204)
(238)
(283)
(329)
(350)
(352)
(343)
(342)
(362)
(370)
(356)
(386)
(377)
(379)
(365)
(379)
(389)
(385)
(375)
(363)
(337)
(319)
(331)
(341)
(349)
(363)
(356)
(371)
(408)
(425)
(452)
(483)
(481)
(472)
(468)
(457)
(446)
(441)
Gross Profit
148
N/A
152
+3%
150
-1%
152
+1%
180
+18%
234
+30%
255
+9%
281
+10%
295
+5%
313
+6%
309
-1%
318
+3%
319
+0%
331
+4%
353
+7%
400
+13%
449
+12%
520
+16%
547
+5%
559
+2%
554
-1%
547
-1%
489
-10%
406
-17%
348
-14%
302
-13%
311
+3%
342
+10%
362
+6%
402
+11%
387
-4%
377
-2%
391
+4%
435
+11%
513
+18%
559
+9%
577
+3%
599
+4%
470
-21%
397
-16%
337
-15%
Operating Income
Operating Expenses
(60)
(69)
(69)
(77)
(96)
(142)
(160)
(176)
(183)
(196)
(193)
(188)
(183)
(197)
(204)
(229)
(252)
(310)
(306)
(316)
(318)
(310)
(275)
(253)
(236)
(195)
(220)
(217)
(218)
(221)
(218)
(223)
(229)
(218)
(227)
(248)
(265)
(289)
(292)
(283)
(265)
Selling, General & Administrative
(62)
(50)
(70)
(79)
(96)
(112)
(160)
(174)
(184)
(131)
(192)
(191)
(178)
(144)
(180)
(205)
(218)
(255)
(273)
(273)
(290)
(258)
(246)
(223)
(200)
(141)
(160)
(159)
(159)
(166)
(161)
(169)
(175)
(165)
(197)
(213)
(226)
(228)
(244)
(234)
(216)
Research & Development
0
(17)
0
0
0
(26)
0
0
0
(51)
0
0
(8)
(44)
(36)
0
(46)
(44)
(38)
(49)
(42)
(41)
(42)
(39)
(38)
(34)
(37)
(38)
(37)
(34)
(38)
(38)
(39)
(35)
(40)
(40)
(43)
(39)
(44)
(45)
(44)
Depreciation & Amortization
0
(1)
0
0
0
(4)
0
0
0
(14)
0
0
0
(16)
0
0
0
(18)
0
0
0
(24)
0
0
0
(23)
0
0
0
(24)
0
0
0
(26)
0
0
0
(29)
0
0
0
Other Operating Expenses
2
(0)
0
1
(1)
(0)
1
(2)
0
(0)
(0)
3
3
7
12
(23)
12
8
5
6
14
13
13
10
3
3
(23)
(21)
(22)
4
(19)
(16)
(15)
8
9
5
4
7
(5)
(4)
(4)
Operating Income
88
N/A
84
-5%
81
-3%
75
-7%
84
+12%
91
+9%
96
+5%
106
+11%
112
+6%
117
+5%
116
-1%
130
+12%
136
+4%
134
-1%
149
+11%
171
+15%
197
+15%
210
+7%
241
+15%
244
+1%
236
-3%
237
+1%
215
-9%
153
-29%
113
-26%
107
-5%
91
-15%
125
+37%
144
+15%
181
+26%
169
-7%
155
-8%
162
+5%
217
+34%
286
+32%
311
+9%
312
+0%
310
-1%
178
-43%
114
-36%
72
-37%
Pre-Tax Income
Interest Income Expense
4
7
8
9
5
0
(5)
(11)
(15)
(17)
(17)
(17)
(16)
(17)
(22)
(22)
(26)
(28)
(36)
(43)
(41)
(39)
(34)
(27)
(28)
(26)
(23)
(22)
(21)
(17)
(17)
(24)
(22)
(21)
(17)
(9)
(7)
(4)
(1)
1
4
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
(0)
(0)
(0)
0
(0)
0
(23)
0
0
0
(23)
0
0
0
(0)
0
0
0
(13)
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
3
3
2
2
2
4
3
4
4
5
5
4
2
3
2
(2)
(2)
(5)
(9)
(5)
(5)
(1)
(4)
(5)
(12)
(5)
6
6
13
7
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
Pre-Tax Income
95
N/A
93
-2%
90
-3%
85
-5%
92
+7%
95
+4%
94
-1%
99
+5%
101
+2%
105
+4%
104
-1%
118
+13%
122
+4%
120
-2%
129
+8%
148
+15%
169
+14%
177
+5%
197
+11%
195
-1%
190
-3%
197
+4%
176
-10%
121
-32%
73
-39%
53
-27%
74
+39%
109
+47%
137
+26%
147
+8%
151
+3%
131
-13%
140
+7%
196
+41%
269
+37%
302
+12%
305
+1%
293
-4%
177
-40%
115
-35%
75
-34%
Net Income
Tax Provision
(13)
(13)
(12)
(12)
(13)
(14)
(14)
(15)
(16)
(11)
(10)
(12)
(12)
(13)
(16)
(20)
(22)
(22)
(26)
(24)
(21)
(25)
(22)
(13)
(7)
(10)
(12)
(17)
(19)
(20)
(20)
(18)
(18)
(18)
(31)
(33)
(36)
(40)
(20)
(11)
(5)
Income from Continuing Operations
82
80
78
74
78
81
81
84
85
95
94
105
110
106
112
128
146
156
171
171
168
172
155
108
66
44
63
92
118
127
131
113
122
178
238
269
269
253
157
104
71
Net Income (Common)
82
N/A
80
-2%
78
-3%
74
-5%
78
+6%
81
+4%
81
-1%
84
+5%
85
+1%
95
+11%
94
-1%
105
+13%
110
+4%
106
-3%
112
+6%
128
+14%
146
+14%
156
+6%
171
+10%
171
+0%
168
-2%
172
+2%
155
-10%
108
-30%
66
-38%
44
-34%
63
+43%
92
+47%
118
+29%
127
+8%
131
+3%
113
-14%
122
+8%
178
+46%
238
+34%
269
+13%
269
+0%
253
-6%
157
-38%
104
-34%
71
-32%
EPS (Diluted)
0.45
N/A
0.4
-11%
0.4
N/A
0.38
-5%
0.39
+3%
0.41
+5%
0.4
-2%
0.42
+5%
0.42
N/A
0.47
+12%
0.46
-2%
0.52
+13%
0.55
+6%
0.53
-4%
0.56
+6%
0.63
+13%
0.72
+14%
0.78
+8%
0.85
+9%
0.85
N/A
0.83
-2%
0.85
+2%
0.76
-11%
0.53
-30%
0.33
-38%
0.22
-33%
0.3
+36%
0.45
+50%
0.59
+31%
0.32
-46%
0.59
+84%
0.53
-10%
0.38
-28%
0.41
+8%
0.74
+80%
0.84
+14%
0.54
-36%
0.55
+2%
0.3
-45%
0.18
-40%
0.14
-22%

See Also

Discover More